99466-56-5

Upstream product

• 1620-55-9 1-phenyl-2-(4-pyridinyl)ethanone 
• 25438-37-3 phenyl(trimethylsiloxy)acetonitrile 
• 1822-51-1 4-picolylchloride hydrochloride 
• 13295-94-8 4-(phenylethynyl)pyridine 
• 408320-71-8 4-(α-bromo-styryl)-pyridine 
• 174844-93-0 4-(2-bromo-2-phenylvinyl)pyridine 

Downstream Products

• 101986-15-6 5-phenyl-6-(4-pyridyl)-2,3-dihydroimidazo<2,1-b>thiazole 

Relevant academic research and scientific papers

MEDICINAL COMPOSITIONS

The present invention relates to an agent for the prophylaxis or treatment of pain, an agent for suppressing activation of osteoclast, and an inhibitor of osteoclast formation, which contains a p38 MAP kinase inhibitor and/or a TNF-α production inhibitor.

Adenosine A3 receptor antagonists

A pharmaceutical composition for antagonizing adenosine at adenosine A3receptors which comprises a 1,3-azole compound substituted on the 4- or 5-position, or both, by a pyridyl which may be substituted is provided and can be used as a prophylactic and therapeutic agent for asthma, allergosis, inflammation, and so on.

Synthese von Pyridylphenyl-imidazothiazolen

The synthesis of the isomeric 6(5)-phenyl-5(6)-pyridyl-2,3-dihydroimidazothiazoles are described.Only the synthesis of 5-phenyl-6-(2-pyridyl)-2,3-dihydroimidazothiazole failed.